SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 424B5 - Prospectus [Rule 424(b)(5)]:
SEC Accession No. 0001193125-18-277677
Filing Date
2018-09-19
Accepted
2018-09-19 16:58:11
Documents
4

Document Format Files

Seq Description Document Type Size
1 424B5 d596211d424b5.htm 424B5 405698
2 GRAPHIC g596211g16b84.jpg GRAPHIC 91247
3 GRAPHIC g596211g20i41.jpg GRAPHIC 28749
4 GRAPHIC g596211g22x07.jpg GRAPHIC 52260
  Complete submission text file 0001193125-18-277677.txt   643881
Mailing Address P. O. BOX # 110341 RESEARCH TRIANGLE PARK NC 27709
Business Address 79 T.W. ALEXANDER DRIVE 4501 RESEARCH COMMONS, SUITE 100 RESEARCH TRIANGLE PARK NC 27709 919-213-9835
G1 Therapeutics, Inc. (Filer) CIK: 0001560241 (see all company filings)

IRS No.: 263648180 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B5 | Act: 33 | File No.: 333-225678 | Film No.: 181078117
SIC: 2834 Pharmaceutical Preparations